'Never seen anything like this' – NIH meetings and travel halted abruptly
Abrupt cancellations of US National Institutes of Health (NIH) meetings, travel, and grant reviews under the new administration are raising alarm among researchers who fear major disruptions to funding, careers, and long-term medical progress. Commenters highlight downstream effects on cancer and intensive care research, training pipelines for young scientists, and the wider US scientific ecosystem, noting that even a short “pause” in approvals can delay projects by months and shut down labs. Some see this as part of a broader ideological push to shrink or privatize government functions, while others argue it accelerates the shift of talent and influence toward Europe, China, and a more multipolar research landscape.
Scope and Nature of the NIH “Pause”
- NIH has abruptly halted meetings, travel, and grant review activities, with poor communication.
- Some commenters think it is part of an ~11‑day pause until Feb 1; others highlight language about reviews being “suspended indefinitely,” calling the situation unclear.
- There is concern that canceling study sections now will push decisions back by months, even if formal operations resume quickly.
Impact on Researchers and Careers
- Strong anxiety for young principal investigators, postdocs, grad students, and early‑career clinicians whose careers hinge on timely NIH grants.
- Examples given of major grants with high scores now in limbo; missing a funding window could end a lab or derail a career.
- People note that many could earn more in clinical practice or industry; undermining research funding is seen as a net loss to taxpayers and public health.
Broader Consequences for Science and Health
- Loss or delay of funding may halt cancer and intensive care research, including work on quality of life, side effects, and repurposing existing drugs.
- Relying on pharmaceutical companies alone is viewed as unrealistic, given their incentives and pricing models.
- Some predict lab closures and job losses; others downplay the pause’s impact, claiming funding is usually disbursed in longer chunks.
Global Talent Flows and US vs. Europe/China
- Commenters predict this will accelerate brain drain from the US to Europe or China, which are portrayed as offering more stability (even if sometimes lower salaries).
- Comparisons highlight European advantages in life expectancy, social safety nets, and work–life balance, versus higher US pay but lower job and funding security.
- China is cited as having already used aggressive hiring and funding in some fields (e.g., physics) as a long‑term strategy.
Political and Ideological Dimensions
- Some see this as part of broader efforts to weaken federal agencies, cut costs, or test which programs generate pushback.
- Others interpret it as ideologically driven sabotage of “woke” or diversity‑related research and institutions.
- Analogies are made to government shutdowns and to “privatize everything” approaches; several argue this is harmful to ordinary people and global health.
Debate Over Government Role and Spending
- One view: government must cut spending and reduce dependency; programs that matter can be privatized or turned into nonprofits.
- Counter‑view: abrupt cuts cannot be made without severe damage; many essential public‑good functions (like medical research) lack a viable private-market substitute.
- Some argue grants have “gone wild” and need realignment, but this claim is only loosely supported in the thread.